New brain scans aim to catch Huntington's cognitive decline earlier
NCT ID NCT07503743
First seen Apr 05, 2026 · Last updated May 01, 2026 · Updated 5 times
Summary
This study aims to create new, more sensitive cognitive tests for Huntington's disease by combining brain imaging (PET and MRI) with blood markers. Researchers will study 90 people—30 healthy controls, 30 gene carriers without symptoms, and 30 early-stage patients—to better understand how thinking changes as the disease progresses. The goal is to improve early detection and support future treatment trials.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUNTINGTON'S DISEASE (HD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hospital de la Sant aCreu i Sant Pau
Barcelona, Spain
Conditions
Explore the condition pages connected to this study.